AzTrials
AzTrials

Mental DistressNCT07231406

Narrative Therapy Among Young People With Moderate Level of Mental Distress in Hong Kong

A study testing Narrative Therapy in people with Mental Distress, run by The University of Hong Kong at 1 site in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This cluster randomized controlled trial (cRCT) aims to evaluate the effectiveness of a narrative therapy (NT) intervention in (i) reducing mental distress, depressive symptoms, and anxiety, as well as (ii) enhancing perceived control and fostering a stronger sense of self among at-risk youth in Hong Kong. Read more about this study

Who is it for?
Ages 12 to 24 years
Conditions the study is for
Mental Distress
What is being tested?
Narrative Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
770 participants
Where
1 siteHong Kong
Study dates
3 Dec 2025to 31 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 24 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • JC LevelMind @ Community users at risk for mental distress (Tier 2), with K6 scores ranging from 11 to 14
  • Aged between 12 and 24 years
  • Sufficiently proficient in Chinese to comprehend verbal instructions
  • Able to provide written informed consent (parental consent for participant aged 12-17)

Who cannot join

  • Known diagnosis of intellectual disability
  • Organic brain disorder
  • Established psychiatric diagnosis
  • Current substance abuse
  • Receiving other structured psychological therapies such as module-based psychological therapy, mentalization-based therapy, low-intensity online interventions, cognitive-behavioral therapy, cognitive-behavioral therapy for insomnia, mindfulness, or art-informed therapy within the hub setting or any others outside the hub setting
  • Presence of current or active suicidal ideation or attempts

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christy Lai Ming Hui, PhD contact

+852 2255 4486

christy@lmhui.com

Yi Nam Suen, PhD contact

+852 3917 6612

suenyn@hku.hk

Hong Kong1 site, 1 recruiting
  • University of Hong Kong

    Hong Kong

    Christy Lai Ming Hui, PhD, +852 2255 4486, christy@lmhui.com

    Recruiting

Other trials in Hong Kong

About this study

Official title: A Cluster Randomized Controlled Trial of Narrative Therapy Among Young People With Moderate Level of Mental Distress in Hong Kong

This cluster randomized controlled trial (cRCT) aims to evaluate the effectiveness of a narrative therapy (NT) intervention in (i) reducing mental distress, depressive symptoms, and anxiety, as well as (ii) enhancing perceived control and fostering a stronger sense of self among at-risk youth in Hong Kong. Participants are youths with moderate mental health concerns, indicated by K6 scores ranging from 11 to 14.

The study involves seven clusters, each based on community hubs, which will be randomly assigned to either the intervention group or a wait-list control group. Clusters assigned to the intervention group will receive six face-to-face sessions led by trained youth workers. Control clusters will receive the same intervention after the initial follow-up period.

Read more

Participants will be evaluated at baseline, post-intervention, and one-month follow-up. An interim analysis is built for the sake of evaluation of the collected data from the ongoing trial, in which the primary research question is addressed, and which has the potential for modifying the conduct of the study. Furthermore, a qualitative follow-up will be conducted after the trial, involving both participants and the workers delivering the NT intervention. This qualitative component aims to gather feedback on participants' experiences, and inform potential revisions to enhance future implementation.

It is hypothesized that youths receiving the NT intervention will show significantly greater improvements in perceived control and sense of self, along with reductions in mental distress, as well as depressive and anxiety symptoms, compared to those in the wait-list control group.

Conditions
Mental Distress
Being tested
Narrative Therapy
Keywords
cluster randomized controlled trial, narrative therapy, youths, mental distress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Narrative TherapyBehavioural

    In Hong Kong, deeply ingrained norms and expectations shape each stage of life. As young people navigate their growth, they are constantly influenced by mainstream narratives stemming from sociocultural traditions, family, educators, peers, or social media. These narratives often define socially approved notions of "good" versus "bad," "meaningful" versus "meaningless," and "successful" versus "failing." Many youths may not fully realize how these dominant discourses subtly influence their life choices, often leading them to unconsciously accept predetermined paths they believe they "should" follow. Whether they conform successfully or struggle with these expectations, young people frequently experience pressure and negative emotions. Even more concerning, some internalize these societal judgments, resulting in negative self-perceptions. Through this group program utilizing narrative intervention methods, we aim to provide a safe, supportive space for youth to re-examine and explore th

Study groups in NCT07231406
Study groupRoleWhat they receive
NT InterventionActive comparatorThis narrative therapy intervention will: (i) facilitate shared experiences among participants, (ii) support the reconstruction of personal identity, (iii) promote collective wisdom-sharing and skill development; and (iv) foster solidarity in imagining diverse life possibilities. This approach empowers young people to critically engage with dominant narratives and discover their own authentic paths. The NT intervention consists of six sessions, conducted in a small-group format (6 - 8 participants per group). Youths at similar life stages, such as secondary students, university students, and early-career young professionals, will be grouped together to encourage meaningful discussions and shared experiences. The program consists of six sessions, with the first five lasting 1.5 hours each, and the final session (Section 6) extending to 2 hours for a comprehensive closing. All sessions will be conducted face-to-face by frontline social or youth workers who have received prior training,
Receives: Behavioral: Narrative Therapy
Waitlist ControlNo interventionParticipants allocated to the waitlist control group will wait for 10 weeks (6 + 4 weeks) before receiving the NT intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychological Distress

    The 6-item Kessler Psychological Distress Scale (scores range from 0 to 24 where a higher score indicates a worse outcome)

    Measured: Baseline, 6-week, and 10-week

  2. Depression and anxiety Symptoms

    Depression Anxiety Stress Scales (scores range from 0 to 63 where a higher score indicates more severe symptoms)

    Measured: Baseline, 6-week, and 10-week

  3. Perceived Control / Self-efficacy

    Sense of Mastery Scale (scores range from 7 to 28 where a higher score indicates a a better outcome)

    Measured: Baseline, 6-week, and 10-week

Secondary outcomes (8)
  1. Narrative Identity

    Narrative Identity Self-Evaluation Scale (scores range from 0 to 200 where a higher score indicates a better outcome)

    Measured: Baseline, 6-week, and 10-week

  2. Perceived Social Support

    Multidimensional Scale of Perceived Social Support (scores range from 12 to 84 where a higher score indicates a better outcome)

    Measured: Baseline, 6-week, and 10-week

  3. Loneliness

    UCLA Loneliness Scale (scores range from 20 to 80 where a higher score indicates a worse outcome)

    Measured: Baseline, 6-week, and 10-week

  4. Resilience

    The 10-item Connor-Davidson Resilience Scale (scores range from 0 to 40 where a higher score indicates a better outcome)

    Measured: Baseline, 6-week, and 10-week

  5. Rumination

    The 22-item Rumination-Reflection Questionnaire (scores range from 22 to 88 where a higher score greater rumination)

    Measured: Baseline, 6-week, and 10-week

  6. Self-stigma

    The 9-item Internalized Stigma of Mental Illness Inventory (scores range from 1 to 4 where a higher score indicating high internalized stigma)

    Measured: Baseline, 6-week, and 10-week

  7. Hopefulness / Hopelessness

    Beck Hopelessness Scale (scores range from 0 to 20 where a higher score indicates greater levels of hopelessness)

    Measured: Baseline, 6-week, and 10-week

  8. Service Utilization

    Client Service Receipt Inventory

    Measured: Baseline, 6-week, and 10-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2025
  2. Study start3 Dec 2025
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
770 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07231406
Sponsor's protocol ID
20250818-006-000
Status last verified
Aug 2025
First submitted
27 Aug 2025
Last updated
30 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Narrative Therapy in people with Mental Distress, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christy Lai Ming Hui, PhD (+852 2255 4486, christy@lmhui.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychological Distress (time frame: Baseline, 6-week, and 10-week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in